Archive: 15/07/2014

Transparency lacking in clinical trials, study finds

A significant percentage of completed drug clinical trials, especially those funded by industry, are not disclosed to the public, years after being completed—a trend that "threatens the validity of the clinical research ...

page 1 from 6